Rotavirus vaccination within the South African Expanded Programme on Immunisation

Vaccine

Volumn 30, Issue SUPPL.3, 2012, Pages

  Seheri, L Mapaseka ^a   Page, Nicola A ^a,b   Mawela, Mothahadini P B ^c   Mphahlele, M Jeffrey ^a   Steele, A Duncan ^a,d  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^c SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^d PATH   (United States)

Author keywords

Epidemiology; Rotavirus; Rotavirus vaccine; South Africa; Vaccine efficacy, Burden of disease

Indexed keywords

POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE;

DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ELECTRON MICROSCOPY; ENZYME IMMUNOASSAY; GENETIC VARIABILITY; GENOTYPE; HEALTH CARE COST; HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; ROTAVIRUS INFECTION; SOUTH AFRICA; VACCINATION; VOMITING;

DIARRHEA; GASTROENTERITIS; HUMANS; IMMUNIZATION PROGRAMS; PRODUCT SURVEILLANCE, POSTMARKETING; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SOUTH AFRICA; VACCINATION; VACCINES, ATTENUATED;

EID: 84865663689     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.018     Document Type: Review

References (70)

1. Estes M.K., Kapikian A.Z. Rotaviruses. Fields virology 2007, 1917-1974. Lippincott Williams 7 Wilkins, Philadelphia, PA. 5th ed. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
2. Parashar U.D., Gibson C.J., Bresee J.S., Glass R.I. Rotavirus and severe childhood diarrhoea. Emerging Infectious Diseases 2006, 12:304-306.
3. Tate J.E., Burton A.H., Boschi-Pinto C., Steele A.D., Duque J., Parashar U.D., et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infectious Diseases 2011, S1473-3099(11):70253-70255.
4. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerging Infectious Diseases 2003, 9:565-571.
5. Bradshaw D., Groenewald P., Laubscher R., Nannan N., Nojilana B., Norman R., et al. Initial burden of disease estimates for South Africa, 2000 2003, South African Medical Research Council, p. 1-84. http://www.mrc.ac.za/bod/bod.htm.
6. Steele A.D., Peenze I., de Beer M., Pager C.T., Yeats J., Potgieter N., et al. Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa. Vaccine 2003, 21:354-360.
7. Mwenda J.M., Ntoto N.K.M., Abebe A., Laryea C.E., Amina I., Diop O.M., et al. Burden and epidemiology of rotavirus diarrhoea in selected African countries - preliminary results from the African Rotavirus Surveillance Network (AFR RSN). Journal of Infectious Diseases 2010, 202:S5-S11.
8. Centers for Disease Control and Prevention (CDC) Rotavirus surveillance - worldwide 2009. Morbidity and Mortality Weekly Report 2011, 60:514-516.
9. Seheri L.M., Dewar J.B., van der Merwe L., Geyer A., Tumbo J., Zweygarth M., et al. Prospective hospital-based surveillance to estimate rotavirus disease burden in the Gauteng and North West Province of South Africa during 2003-2005. Journal of Infectious Diseases 2010, S131-S138.
10. Communicable Diseases Surveillance Bulletin, NICD, NHLS 2010, 8(1):11-14.
11. District health information system database 2011, Nation Department of Health, [accessed October 2011]. http://www.indicators.hst.org.za/healthstats/316/data.
12. Ward R.L., Bernstein D.I., Knowlton D.R., Sherwood J.R., Young E.C., Cusack T.M., et al. Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray. Journal of Clinical Microbiology 1991, 29:1991-1996.
13. Denney P.H. Transmission of rotavirus and other enteric pathogens in the home. Pediatric Infectious Disease Journal 2000, 19:103-105.
14. Steele A.D., Alexander J.J. Molecular epidemiology of rotavirus in black infants in South Africa. Journal of Clinical Microbiology 1987, 25:2384-2387.
15. Bishop R.F. Natural history of human rotavirus infection. Viral infections of gastrointestinal tract 1994, 131-167. Marcel Dekker, Inc, New York/Basel/Hong Kong. 2nd ed. A.Z. Kapikian (Ed.).
16. Christensen M.L. Human viral gastroenteritis. Clinical Microbiology 1989, 2:51-89.
17. Binka F.N., Anto F.K., Oduro A.R., Awini E.A., Nazzar A.K., Armah G.E., et al. Incidence and risk factors of paediatric rotavirus diarrhoea in northern Ghana. Tropical Medicine and International Health 2003, 8:840-846.
18. Nokes J.D., Abawao J., Pamba A., Peenze I., Dewar J., Maghenda J.K., et al. Incidence and clinical characteristics of group A rotavirus infections among children admitted to hospital in Kilifi, Kenya. PLoS Medicine 2008, 5:1154-1162.
19. Koopmans M., Brown D. Seasonality and diversity of group A rotaviruses in Europe. Acta Paediatrica. Supplement 1999, 426:14-19.
20. Kim J.S., Kang J.O., Cho S.C., Jang Y.T., Min S.A., Park T.H., et al. Epidemiology profile of rotavirus infection in the Republic of Korea: results from prospective surveillance in the Jeongeub district, 1 July 202 through 30 June 2004. Journal of Infectious Diseases 2005, 192:S49-S56.
21. Nakagomi T., Nakagomi O., Takahashi Y., Suzuki T., Kilgore P.E. Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. Journal of Infectious Diseases 2005, 192:S106-S110.
22. Gleizes O., Desselberger U., Tatochenko V., Rodrigo C., Salman N., Mezner Z., et al. Nosocomial rotavirus infection in European countries; A review of the epidemiology, severity and economic burden of hospital acquired rotavirus disease. Pediatric Infectious Disease Journal 2006, 25:S12-S21.
23. Cook S.M., Glass R.I., Le Baron C.W., Ho M.S. Global seasonality of rotavirus infections. Bulletin of the World Health Organization 1990, 68:171-177.
24. Steele A.D., Alexander J.J., Hay I.T. Rotavirus associated gastroenteritis in black infants in South Africa. Journal of Clinical Microbiology 1986, 23:992-994.
25. Cunliffe N.A., Kilgore P.E., Bresee J.S., Steele A.D., Luo N., Hart C.A., et al. Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bulletin of the World Health Organization 1998, 76:525-537.
26. Bishop R.F. Natural History of Human Rotavirus Infection. Archives of Virology Supplement 1996, 96:119-127.
27. Giaquinto C., Van Damme P., REVEAL Study Group Age distribution of paediatric rotavirus gastroenteritis case in Europe: the REVEAL study. Scandinavian Journal of Infectious Diseases 2010, 42:142-147.
28. Glass R.I., Kilgore P.E., Holman R.C., Jin S., Smith J.C., Woods P.A., et al. The epidemiology or rotavirus diarrhoea in the United States; surveillance and estimates of disease burden. Journal of Infectious Diseases 1996, 174:S5-S11.
29. Matthijnssens J., Ciarlet M., Rahman M., Attoui H., Banyai K., Estes M., et al. Recommendation for the classification of group A rotaviruses using all 11 genomic RNA segments. Archives of Virology 2008, 153:1621-1629.
30. Matthijnssens J., Ciarlet M., McDonald S.M., Attoui H., Banyai K., Brister J.R., et al. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Archives of Virology 2011, 156:1397-1413.
31. Steele A.D., van Niekerk M.C., Mphahlele M.J. Geographic distribution of human rotavirus VP4 genotypes and VP7 serotypes in five South African regions. Journal of Clinical Microbiology 1995, 33:1516-1519.
32. Franco M.A., Angel J., Greenberg H.B. Review: immunity and correlates of protection of rotavirus vaccines. Vaccine 2006, 24:2718-2731.
33. Gouvea V., de Castro L., Timenetsky C., Greeberg H., Santos N. Rotavirus serotypes G5 associated with diarrhoea in Brazilian children. Journal of Clinical Microbiology 1994, 32:1408-1409.
34. Esona M.D., Armah G.E., Geyer A., Steele A.D. Detection of an unusual human rotavirus strain with G5P[8] specificity in a Cameroonian child with diarrhoea. Journal of Clinical Microbiology 2004, 42:441-444.
35. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes ant its implication for the development and implementation of an effective rotavirus vaccine. Reviews in Medical Virology 2005, 15:29-56.
36. Sanchez-Padilla E., Grais R.F., Guerin P.J., Steele A.D., Burny M.E., Luguero F.J. Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis. Lancet Infectious Diseases 2009, 9:567-576.
37. Trabelsi A., Peenze I., Pager C., Jeddi M., Steele A.D. Distribution of rotavirus VP7 serotypes and VP4 genotypes circulating in Sousse, Tunisia from 1995-1999: emergence of natural human reassortants. Journal of Clinical Microbiology 2000, 38:3415-3419.
38. Pennap G., Peenze I., de Beer M., Pager C.T., Kwaga J.K.P., Ogalla W.N., et al. VP6 subgroup and VP7 serotypes of human rotavirus in Zaria, Northern Nigeria. Journal of Tropical Pediatrics 2000, 46:344-347.
39. Armah G., Pager C.T., Asmah R.H., Anto F.R., Oduro A.R., Binka F., et al. Prevalence of unusual human rotavirus strains in Ghananian children. Journal of Medical Virology 2001, 63:67-71.
40. Steele A.D., Ivanoff B. Rotavirus strains circulating in Africa during 1996-1999: emergence of G9 strains and P[6] strains. Vaccine 2003, 21:361-367.
41. Fischer T.K., Page N.A., Griffin D.D., Eugen-Olsen J., Pedersen A.G., Valetiner-Branth P., et al. Characterization of incompletely typed rotavirus strains from Guinea-Bissau: identification of G8 and G9 types and a high frequency of mixed infections. Virology 2003, 311:125-133.
42. Bonkoungou I.J.O., Damanka S., Sanou I., Triendrebeogo F., Coulibaly S.O., Bon F., et al. Genotype diversity of group A rotavirus strains in children with acute diarrhoea in urban Burkina Faso, 2008-2010. Journal of Medical Virology 2011, 83:1485-1490.
43. Steele A.D., Parker S.P., Peenze I., Pager C.T., Taylor M.B., Cubitt W.D. Comparative studies of rotavirus serotype G8 strains recovered in South Africa and the United Kingdom. Journal of General Virology 1999, 80:3029-3034.
44. Adah M.I., Ronwedder A., Olaleyle O.D., Werchau H. Further characterization of field strains of rotavirus from Nigeria VP4 genotype P6 frequently identified among symptomatically infected children. Journal of Tropical Pediatrics 1997, 43:267-274.
45. Cunliffe N.A., Gondwe J.S., Broadhead R.L., Molyneux M.E., Woods P.A., Bresee J.S., et al. Rotavirus G and P types in children with acute diarrhoea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6] G8 strains. Journal of Medical Virology 1999, 57:308-312.
46. Taniguchi K., Urasawa T., Kobayashi M., Gorziglia M., Urasawa S. Nucleotide sequence of VP4 and VP7 genes of human rotaviruses with subgroup I specificity and long RNA pattern: implication for the new G serotype specificity. Journal of Virology 1990, 64:5640-5644.
47. Shinozaki K., Okda M., Nagashima S., Kaiho I., Taniguchi K. Characterization of human rotavirus strains with G12 and P[9] detected in Japan. Journal of Medical Virology 2004, 73:612-616.
48. Rahman M., Matthijnssens J., Yang X., Delbeke T., Arijs I., Taniguchi K., et al. Evolutionary history and global spread of the emerging G12 human rotaviruses. Journal of Virology 2007, 81:2382-2390.
49. Page N.A., de Beer M.C., Seheri L.M., Dewar J.B., Steele A.D. The detection and molecular characterization of human G12 genotypes in South Africa. Journal of Medical Virology 2009, 81:106-113.
50. Sarker S.A., Casswall T.H., Mahalanabis D., Alam N.H., Albert M.J., Brussow H., et al. Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrums. Journal of Pediatric Infectious Disease 1998, 12:1149-1154.
51. Centers for Disease Control and Prevention Intussusception among recipients of rotavirus vaccine in United States 1998-1999. Morbidity and Mortality Weekly Report 1999, 48:577-581.
52. Joensuu J., Koskenniemi E., Xiao-Li P., Vesikari T. Randomized placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997, 350:1205-1209.
53. Perez-Schael I., Guntinas M.J., Perez M., Pagone V., Rojas A.M., Gonzalez R., et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. New England Journal of Medicine 1997, 337:1181-1187.
54. Kirkwood C.D., Boniface K., Barnes G.L., Bishop F.R. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix and Rotateq, into the national immunization program of Australia. Pediatric Infectious Disease Journal 2011, 30:S48-S53.
55. WHO Report of the meeting on future directions for rotavirus vaccine research in developing countries 2000, World Health Organization, WHO/V&B/00, Geneva, p. 1-56. http://www.who.int/vaccines-document/DocsPDF00/www531.pdf.
56. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abeate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New England Journal of Medicine 2006, 354:11-22.
57. Vesikari T., Matson D.O., Dennehy S.E., Van Damme P., Santosham M., Rodrieguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccines. New England Journal of Medicine 2006, 354:23-33.
58. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Cohen R., et al. Efficacy of human rotavirus against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007, 24:1757-1763.
59. Madhi S.A., Cunliffe N.A., Steele A.D., Witte D., Kirsten M., Louw C., et al. Effect of human rotavirus vaccine on severe diarrhoea in Africa infants. New England Journal of Medicine 2010, 362:289-298.
60. Armah G.E., Sow S.O., Breiman R.F., Dallas M.J., Tapia M.D., Feikin D.R., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blinded, placebo-controlled trial. Lancet 2011, 9741:606-614.
61. Zaman K., Dang D.A., Victor J.C., Shin S., Yunus M., Dallas M.J., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:615-623.
62. World Health Organization Meeting of the strategic advisory group of experts, April 2009 - conclusion and recommendations. Weekly Epidemiological Record 2009, 84:220-236.
63. Steele A.D., Alexander J.J., Hay I.T. Rotavirus-associated gastroenteritis at Ga-Rankuwa. A pilot study. South African Medical Journal 1986, 69:21-22.
64. Malek M.A., Curns A.T., Holman R.C., Fischer T.K., Bresee J.S., Glass R.I., et al. Diarrhea- and rotavirus-associated hospitalization among children less than 5 years of age: United States, 1997 and 2000. Pediatrics 2006, 117:1887-1892.
65. MacIntyre U.E., De Villiers F.P.R. The economic burden of diarrhoeal diseases in a tertiary level hospital, Gauteng, South Africa. Journal of Infectious Diseases 2010, 202:S116-S125.
66. Steele A.D., De Vos B., Tumbo J., Reynders J., Scholtz F., Bos P., et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. Vaccines 2010, 28:6542-6548.
67. Steele A.D., De Vos B., Tumbo J., Reynders J., Scholtz F., Bos P., et al. Comparison of 2 different regimens for reactogenicity, safety and immunogenicity of live attenuated oral vaccine RIX4414 co-administered with oral polio vaccine in South African Infants. Journal of Infectious Diseases 2010, 202:S93-S99.
68. Steele A.D., Madhi S.A., Louw C.E., Bos P., Tumbo J.M., Werner C.M., et al. Safety, reactogenicity, and immunogenicity of human rotavirus vaccine RIX4414 in human immunodeficiency virus-positive infants in South Africa. Pediatric Infectious Disease Journal 2011, 30:125-130.
69. Tate J.E., Panozzo C.A., Payne D.C., Patel M.M. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009, 124:465-471.
70. Zeller M., Rahman M., Heylen E., De Coster S., De Vos S., Arijs I., et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine 2010, 28:7507-7513.